Aluminum is a ubiquitous environmental element with established neurotoxic effects, particularly in individuals with impaired renal function or high exposure levels.
Environmental exposure also occurs through air, soil, cosmetics, antiperspirants, and medications such as antacids
Individuals are exposed to aluminum in air, soil, and water.
Aluminum is present in drinking water, processed and unprocessed foods, and common personal products, such as cosmetics, antiperspirants, medications, and vaccines.
People are exposed through inhalation, congestion, and dermal contact.
Medical exposures of aluminum occur through injection, vaccines, medications, ingestion – antiacids, buffered aspirin, or dermal contact – first aid products.
Aluminum comprises 8 to 9% of the earths crust, making it the most abundant medal and third most common element on the Earth’s surface.
The primary health concerns relate to neurotoxicity, bone disease, and potential cognitive impairment, though the relationship with Alzheimer’s disease remains controversial.
Many aluminum compounds have niche applications, for example:
Aluminum acetate in solution is used as an astringent.
Aluminum phosphate is used in the manufacture of glass, ceramic, pulp and paper products, cosmetics, paints, varnishes, and in dental cement.
It is used to make building materials, cooking instruments, food, and beverage containers, and fireworks.
Aluminum is used in paper, dies, textiles, and glass industries, water purification, solid fuel, rocket fuels, oil refining, and is a component of paints and pigments.
Aluminum hydroxide is used as an antacid, it is used also in water purification, the manufacture of glass and ceramics, and in the waterproofing of fabrics.
Lithium aluminum hydride is a powerful reducing agent used in organic chemistry.
In many vaccines, certain aluminum salts serve as an immune adjuvant in many vaccines. to allow the protein in the vaccine to achieve sufficient potency as an immune stimulant.
Recommended vaccines in the first two years of life could expose an infant to up to 4.4 mg of aluminum if given separately, but combination vaccines has reduced this intake significantly.
Aluminum has no known function in biology.
Aluminum in the bloodstream binds with transferrin, citrate, hydroxide, and phosphate.
Approximately 50 to 70% is excreted in the urine within 24 hours and approximately 83% within two weeks.
Small quantities of aluminum about 2% remain in the body for years.
Aluminum accumulates in most issues, most commonly the skeleton, muscles, kidneys, liver, and brain.
Significant amounts of aluminum are found in lung tissue attributed to inhalational exposure.
Adults have between between 30 and 50 mg of aluminum in their bodies, mostly from dietary exposures, with approximately 1/2 detected in bones, and 1/4 in the lungs.
It is estimated the average US adult ingests 7 to 9 mg of aluminum daily.
Infants consume aluminum from breastmilk and infant formulas.
Soy base formulas contain greater quantities the milk based formulas.
Normal aluminum serum levels are 1 to 3 µg per liter.
Aluminum is classified as a non-carcinogen by the United States Department of Health and Human Services.
There is little evidence that normal exposure to aluminium presents a risk to healthy adult, and a multi-element toxicology review was unable to find deleterious effects of aluminium consumed in amounts not greater than 40 mg/day per kg of body mass.
Most aluminum consumed will leave the body in feces; most of the small part of it that enters the bloodstream, will be excreted via urine.
Most people efficiently process aluminum, preventing its toxicity.
Some aluminum does pass the blood-brain barrier and is lodged preferentially in the brains of Alzheimer’s patients, and may act by electrostatically crosslinking proteins, thus down-regulating genes in the superior temporal gyrus.
Deposition in bone secondary to aluminum-based phosphate binders interferes with bone mineralization.
Health effects tend to first appear in bones, with the greatest quantities of aluminum accumulate under normal circumstances.
Aluminum related bone disease, historically dialysis osteomalacia results in skeletal pain annd increased likelihood of fractures.
Scientists have found that people with Alzheimer’s, autism, and MS have significantly more aluminum in their brains than others.
Aluminum, rarely, can cause vitamin D-resistant osteomalacia, erythropoietin-resistant microcytic anemia, and central nervous system alterations: People with kidney insufficiency are especially at a risk.
Chronic ingestion of hydrated aluminium silicates, as for excess gastric acidity control may result in aluminium binding to intestinal contents and increased elimination of other metals, such as iron or zinc; sufficiently high doses can cause anemia.
Aluminum has been suspected of being a possible cause of Alzheimer’s disease, but research has found no good evidence of causal effect.
At very high doses, aluminium is associated with altered function of the blood–brain barrier.
A small percentage of patients have contact allergies to aluminum and experience itchy red rashes, headache, muscle pain, joint pain, poor memory, insomnia, depression, asthma, irritable bowel syndrome, or other symptoms upon contact with products containing aluminum.
Exposure to powdered aluminum or aluminum welding fumes can cause pulmonary fibrosis.
Food is the main source of aluminum.
Drinking water contains more aluminum than solid food, however, aluminum in food may be absorbed more than aluminium from water.
The major sources of human exposure to aluminum include food-food additives, food and beverage packaging, and cooking utensils, drinking water due to its use in municipal water treatment, and aluminum-containing medications particularly antacid/antiulcer and buffered aspirin formulations.
Higher exposure levels of aluminum are mostly limited to miners, aluminium production workers, and dialysis patients.
Consumption of antacids, antiperspirants, vaccines, and cosmetics provide possible routes of exposure.
Consumption of acidic foods or liquids with aluminium enhances aluminum absorption.
Gastrointestinal absorption varies significantly by chemical form, with citrate-associated aluminum showing 0.5-5% absorption compared to only 0.01% for hydroxide forms.
Aluminum is the most abundant metal in Earth’s crust
Most people are exposed to aluminum through food, drinking water, and some consumer products.
The average person consumes 7-9mg of aluminum daily through food.
The average US adult ingests 7-9 mg of aluminum daily from food and beverages, with infants consuming varying amounts depending on feeding method: approximately 5 mg from breast milk, 19 mg from milk-based formula, or 127 mg from soy-based formula during the first 6 months of life.
Common dietary sources include processed foods with aluminum-containing additives, drinking water treated with aluminum salts, tea, and foods cooked or stored in aluminum containers.
For healthy individuals with normal kidney function, aluminum exposure from everyday sources poses minimal risk.
The body efficiently eliminates most aluminum through urine.
People with impaired kidney function may accumulate aluminum since they cannot filter it effectively.
Certain groups warrant attention: patients with chronic kidney disease, especially those on dialysis, infants on soy-based formulas, and individuals with high occupational exposure.
Aluminum toxicity primarily affects individuals with chronic kidney disease, where impaired renal clearance leads to accumulation.
In dialysis patients, neurotoxicity typically occurs at blood aluminum concentrations above 467 µg/L, while bone disease develops at lower concentrations around 142 µg/L.
Workers in aluminum’s production facilities or related industries may experience higher exposure levels, potentially leading to respiratory issues like pulmonary fibrosis with long-term, heavy exposure.
Modern anodized aluminum cookware is generally considered safe.
Acidic foods may increase aluminum leaching, but levels remain well below safety thresholds.
The scientific consensus does not support aluminum as a primary risk factor for Alzheimer’s disease.
Some vaccines contain aluminum salts as adjuvants.
These small amounts help stimulate immune response and have demonstrated safety through extensive research.
Aluminum exposure from vaccines (maximum ~12 mg over a lifetime) is substantially lower than dietary exposure (468-2785 mg over a lifetime).
Regulatory agencies worldwide consider normal environmental aluminum exposure safe for most people, with a tolerable weekly intake of 2mg/kg body weight.
The European Food Safety Authority established a tolerable weekly intake (TWI) of 1 mg/kg body weight/week, though some populations may exceed this threshold, particularly infants on soy-based formulas and young children.
The only treatment for massive exposure is deferoxamine mesylate which may be given to help eliminate aluminium from the body by chelation therapy: this reduces not only aluminium body levels, but also those of other metals such as copper or iron.
The aluminum industry generates about 70 million tons of this waste annually.
High levels of aluminum are present near mining sites and small amounts of aluminium are released to the environment at coal-fired power plants or incinerators.
Aluminum in the air is washed out by the rain or normally settles.
Small particles of aluminum remain in the air for a long time.
Acidic precipitation is the main factor to mobilize aluminum from natural sources, and the main reason for the environmental effects of aluminum.
The main factor of presence of aluminium in salt and freshwater are the industrial processes that also release aluminium into air.
Greenhouse gas emissions.result from electrical consumption of the smelters and the byproducts of processing.
Chronic aluminum exposure is associated with cognitive impairment affecting memory, processing speed, and working memory.
A meta-analysis found significantly inferior global cognitive scores in aluminum-exposed individuals compared to unexposed populations.
Mechanisms of neurotoxicity include oxidative stress, mitochondrial dysfunction, disruption of neurotransmitter systems, and impaired synaptic plasticity.
Neuroimaging studies demonstrate gray matter volume reduction in the hippocampus and frontal lobes, along with disrupted functional connectivity.
The relationship between aluminum and Alzheimer’s disease (AD) remains highly debated.
A 2025 meta-analysis found a strong association between environmental aluminum exposure and AD risk, though with high heterogeneity.
Aluminum promotes formation of insoluble amyloid-beta protein and hyperphosphorylated tau, hallmarks of AD pathology.
Epidemiological studies have produced inconsistent findings, with only some showing associations between drinking water aluminum concentrations and dementia incidence.
Current evidence suggests aluminum may be one of several interacting risk factors rather than a sole causative agent.
For the general population with normal renal function consuming typical Western diets, aluminum exposure from food and water appears to pose minimal risk.